1,3-propanediol has been researched along with Psychotic Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| SELLING, LS | 1 |
| BORRUS, JC | 1 |
2 other study(ies) available for 1,3-propanediol and Psychotic Disorders
| Article | Year |
|---|---|
Clinical study of a new tranquilizing drug; use of miltown (2-methyl-2-n-propyl-1,3-propanediol dicarbamate).
Topics: Glycols; Meprobamate; Muscle Relaxants, Central; Neurotic Disorders; Propylene Glycol; Propylene Glycols; Psychotherapy; Psychotic Disorders; Tranquilizing Agents | 1955 |
Study of effect of miltown (2-methyl-2-n-propyl-1,3-propanediol dicarbamate) on psychiatric states.
Topics: Glycols; Meprobamate; Muscle Relaxants, Central; Neurotic Disorders; Propylene Glycol; Propylene Glycols; Psychotherapy; Psychotic Disorders | 1955 |